Nabriva (NBRV) Prices 6M Share Common Offering at $2.50/Sh

Nabriva Therapeutics plc (NASDAQ: NBRV) today announced the pricing of its public offering of 6,000,000 ordinary shares (or pre-funded warrants in lieu thereof) at an effective offering price to the public of $2.50 per share (or pre-funded warrant).

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. Northland Securities, Inc. is acting as financial advisor in connection with the offering.

The gross proceeds to Nabriva Therapeutics from the offering, before deducting the placement agent’s fees and other estimated offering expenses payable by Nabriva Therapeutics, are $15 million. The offering is expected to close on or about December 15, 2020, subject to the satisfaction of customary closing conditions.

The securities described above are being offered and sold in this offering pursuant to a shelf registration statement, including a prospectus, on Form S-3 that was filed by Nabriva Therapeutics with the Securities and Exchange Commission (“SEC”) and was declared effective on September 11, 2020.

You May Also Be Interested In

• FuelCell Energy prices $225M stock offering at $21 per share
• FuelCell Energy launches $200M common stock offering
• Goldman Sachs Reiterates Buy Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)